Raday Gilead
Reporting owner on Forms 3, 4 and 5, CIK 2113137.
Raday Gilead reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-06.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| RDHL · RedHill Biopharma Ltd.CIK 1553846 | officer (Chief Operating Officer) | 1 | 2026-10-06 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| RDHL · RedHill Biopharma Ltd.Ordinary Shares | 2026-10-01 | S sold | -14,310,000 | $0.0001 | 176,910,000 | Form 4 |
| RDHL · RedHill Biopharma Ltd.American Depository Shares, derivative | 2026-10-01 | M exercised | +27,560,000 | $0 | 131,690,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001178913-26-004715 | RedHill Biopharma Ltd. | 2026-10-06 |